OSR (OSRH) Competitors $0.98 +0.02 (+2.08%) As of 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesSEC FilingsTrendsBuy This Stock OSRH vs. CTCX, NSPR, SRTS, ZYXI, MDAI, SPAI, CTSO, SURG, RBOT, and ICCMShould you be buying OSR stock or one of its competitors? The main competitors of OSR include Carmell (CTCX), InspireMD (NSPR), Sensus Healthcare (SRTS), Zynex (ZYXI), Spectral AI (MDAI), Safe Pro Group (SPAI), Cytosorbents (CTSO), SurgePays (SURG), Vicarious Surgical (RBOT), and IceCure Medical (ICCM). These companies are all part of the "medical equipment" industry. OSR vs. Its Competitors Carmell InspireMD Sensus Healthcare Zynex Spectral AI Safe Pro Group Cytosorbents SurgePays Vicarious Surgical IceCure Medical OSR (NASDAQ:OSRH) and Carmell (NASDAQ:CTCX) are both small-cap medical equipment companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, risk, media sentiment, institutional ownership, earnings, valuation and profitability. Do institutionals and insiders hold more shares of OSRH or CTCX? 55.3% of OSR shares are owned by institutional investors. Comparatively, 24.2% of Carmell shares are owned by institutional investors. 33.7% of OSR shares are owned by company insiders. Comparatively, 29.0% of Carmell shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Which has more volatility & risk, OSRH or CTCX? OSR has a beta of 1.56, meaning that its share price is 56% more volatile than the S&P 500. Comparatively, Carmell has a beta of 0.51, meaning that its share price is 49% less volatile than the S&P 500. Does the media refer more to OSRH or CTCX? In the previous week, OSR had 3 more articles in the media than Carmell. MarketBeat recorded 3 mentions for OSR and 0 mentions for Carmell. OSR's average media sentiment score of 0.62 beat Carmell's score of 0.00 indicating that OSR is being referred to more favorably in the media. Company Overall Sentiment OSR Positive Carmell Neutral Is OSRH or CTCX more profitable? OSR's return on equity of -36.89% beat Carmell's return on equity.Company Net Margins Return on Equity Return on Assets OSRN/A -36.89% -19.14% Carmell N/A -217.50%-50.22% Which has better valuation and earnings, OSRH or CTCX? OSR has higher earnings, but lower revenue than Carmell. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOSRN/AN/A-$2.41MN/AN/ACarmell$32.84K2,584.56-$15.44MN/AN/A SummaryOSR beats Carmell on 8 of the 9 factors compared between the two stocks. Get OSR News Delivered to You Automatically Sign up to receive the latest news and ratings for OSRH and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding OSRH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart OSRH vs. The Competition Export to ExcelMetricOSRUNCLASSIFIED IndustryManufacturing SectorNASDAQ ExchangeMarket Cap$18.89M$185.90M$2.18B$9.51BDividend YieldN/AN/A2.57%3.99%P/E RatioN/A0.9522.1420.03Price / SalesN/A55.0490.60103.88Price / CashN/A76.5628.9259.01Price / Book-0.2559.7159.775.90Net Income-$2.41M-$1.39M-$121.56M$258.66M7 Day Performance-7.55%0.86%0.91%2.23%1 Month Performance-21.60%6.27%2.65%12.77%1 Year PerformanceN/A107.94%25.96%19.36% OSR Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)OSRHOSRN/A$0.98+2.1%N/AN/A$18.89MN/A0.00N/ANews CoverageCTCXCarmellN/A$3.63-16.0%N/A+316.0%$75.89M$32.84K0.0014NSPRInspireMD2.5395 of 5 stars$2.39-0.8%$4.50+88.3%-14.4%$73.22M$7.03M-3.1950SRTSSensus Healthcare1.1291 of 5 stars$4.34-2.3%$11.67+168.8%-11.0%$71.37M$39.49M43.4040News CoverageZYXIZynex2.1784 of 5 stars$2.31-1.7%$5.50+138.1%-74.9%$71.06M$192.35M-9.62770Upcoming EarningsMDAISpectral AI3.5112 of 5 stars$2.51-6.0%$4.75+89.2%+51.4%$67.60M$29.96M-4.6583SPAISafe Pro Group0.7304 of 5 stars$4.00-8.0%$8.00+100.0%N/A$66M$2.17M-4.9411Positive NewsGap DownCTSOCytosorbents1.6677 of 5 stars$1.03+4.0%$5.50+434.0%-1.0%$61.98M$35.60M-3.68220Gap UpSURGSurgePays3.1503 of 5 stars$2.91-1.0%$9.00+209.3%-1.9%$60.01M$60.88M-1.0440RBOTVicarious Surgical0.3751 of 5 stars$10.31+2.6%$8.50-17.5%+77.7%$59.54MN/A-0.99210Gap DownICCMIceCure Medical2.3261 of 5 stars$1.02+1.0%$2.50+145.1%+20.1%$59.28M$3.29M-3.6460News CoverageGap Up Related Companies and Tools Related Companies Carmell Alternatives InspireMD Alternatives Sensus Healthcare Alternatives Zynex Alternatives Spectral AI Alternatives Safe Pro Group Alternatives Cytosorbents Alternatives SurgePays Alternatives Vicarious Surgical Alternatives IceCure Medical Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:OSRH) was last updated on 7/25/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredHow to Collect Up To $5,917/mo From Trump’s Made In USA BoomHow to Collect Up To $5,917/mo From Trump's Made In USA Boom Thanks to President Trump's America-First poli...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding OSR Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share OSR With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.